[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BiotechTV BiotechTVBiotechTV posts on X about ceo, ash, $alks, $xene the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence finance XXXXX% travel destinations XXXX% stocks XXXX% cryptocurrencies XXXX% technology brands XXXX%
Social topic influence ceo #1398, ash 8.33%, $alks 5.56%, $xene 5.56%, $tern #13, $legn #9, $onc #7, london 5.56%, $qure 2.78%, events XXXX%
Top accounts mentioned or mentioned by @financebully @stifel @stifelinsts @beonemedicines @johnvoyler @arcellx @ternspharma @kitepharmas @arcellxs @compugenltd @matteispaul @protagonisttxs @pnosker @vieventures @chugaicc @organox @kymeratxs @nellomainolfi @regenxbios @stifelinst
Top assets mentioned Alkermes Inc. plc (ALKS) Xenon Pharmaceuticals Inc (XENE) Terns Pharmaceuticals, Inc. Common Stock (TERN) One Cash (ONC) uniQure N.V. (QURE) Dyne Therapeutics, Inc. Common Stock (DYN) Protagonist Therapeutics, Inc (PTGX) Bitcoin Incognito (XBI) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Kymera Therapeutics, Inc. Common Stock (KYMR) Arcellx, Inc. Common Stock (ACLX) Celcuity Inc. Common Stock (CELC) Disc Medicine, Inc. Common Stock (IRON) Summit Therapeutics Inc. Common Stock (SMMT) Sanofi (SNY)
Top posts by engagements in the last XX hours
": @StifelInst's Head of Therapeutics Research @MatteisPaul shares his take on the sector and discusses names he covers that have key catalyst events. @Stifel $QURE $ALKS $XENE $CMPS $GHRS $MNMD $DYN Full video:"
X Link 2025-11-11T16:53Z 9895 followers, 2976 engagements
": During an event at Legend Biotech's new R&D Center in Philadelphia today a CAR-T recipient had some words for the biotech industry"
X Link 2025-11-13T22:48Z 9888 followers, 5772 engagements
": @ProtagonistTx's CEO Dinesh Patel responds to takeout speculation and discusses the company's programs and culture of partnering. $PTGX Full video:"
X Link 2025-11-18T12:31Z 9895 followers, 27.4K engagements
": Affinity Asset Advisors' @pnosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:"
X Link 2025-11-19T15:29Z 9893 followers, 13.4K engagements
": Two veterans from MPM have launched a new VC firm @VieVentures that will focus on investing in the I&I space - and it will leverage collaborations with disease specific philanthropies. Full video:"
X Link 2025-12-05T12:30Z 9899 followers, 1696 engagements
": An overview of @chugai_cc including its global ambitions and R&D capabilities with the companys CEO Dr. Osamu Okuda in Tokyo. Full video:"
X Link 2024-11-15T00:48Z 9910 followers, 24.7K engagements
": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:"
X Link 2025-10-10T13:43Z 9911 followers, 1251 engagements
": Zealand Pharma CEO Adam Steensberg (strongly) believes that amylins will overtake GLPs as the backbones of obesity treatments in the future. Full video:"
X Link 2025-11-18T20:29Z 9911 followers, 11.4K engagements
": "A special drug like this does not come around every day." @TernsPharma CEO Amy Burroughs previews the company's upcoming ASH presentation for tern-701 in relapsed/refractory cml. $TERN Full video:"
X Link 2025-11-19T18:19Z 9911 followers, 3338 engagements
": @KymeraTx's Founder & CEO @NelloMainolfi recaps Monday's STAT6 data and discusses the next steps in development. $KYMR Full video:"
X Link 2025-12-10T23:35Z 9910 followers, 3479 engagements
": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video:"
X Link 2025-06-14T19:48Z 9907 followers, 7413 engagements
": Oppenheimer Analyst Matthew Biegler discusses the breast cancer space and comments on key names. $CELC $RLAY $OLMA Full video:"
X Link 2025-11-06T19:42Z 9903 followers, 2900 engagements
": The early part of 2026 is going to be a key time for @REGENXBIO's gene therapies with an FDA decision date scheduled for Hunter's Syndrome and a pivotal trial readout in DMD. $RGNX @Stifel @StifelInst Full video:"
X Link 2025-11-11T19:18Z 9909 followers, 1809 engagements
": Legend Biotech CEO Ying Huang shares a post-earnings update from the company's new R&D Center in Philadelphia. $LEGN Full video:"
X Link 2025-11-13T21:18Z 9907 followers, 1802 engagements
": @BeOneMedicines announced a phase X success for its HER2 bispecific today in gastric cancer. @johnvoyler walks us through that and the whole pipeline. $ONC Full video:"
X Link 2025-11-17T17:11Z 9907 followers, 2686 engagements
": @BeOneMedicines CEO @johnvoyler on the state of biotech modalities and SF vs London. $ONC"
X Link 2025-11-17T17:47Z 9907 followers, 1937 engagements
": At the industry's biggest conferences biotech leaders speak with BiotechTV. Catch our coverage of the 2025 ASH Annual Meeting from Sat through Tues.🩸"
X Link 2025-12-05T16:00Z 9906 followers, 5872 engagements
": @LegendBiotech CEO Ying Huang discusses new long-term Carvykti data looming competition a CD19+CD20 program and in vivo CAR-T. $LEGN Full video:"
X Link 2025-12-06T19:44Z 9908 followers, 3596 engagements
": @DiscMedicine CEO John Quisel walks us through the RALLY-MF Phase X trial data of DISC-0974 in anemia of myelofibrosis. $IRON Full video:"
X Link 2025-12-07T17:35Z 9907 followers, 2028 engagements
": A deep-dive discussion on obesity drug development with Zealand Pharma's CEO Adam Steensberg. Full video:"
X Link 2024-10-10T18:04Z 9909 followers, 38K engagements
": @MenloVentures published a report showing that the healthcare industry is the leading adopter of AI - @derekgxiao one of the co-authors shares key takeaways. Full video:"
X Link 2025-11-05T14:00Z 9909 followers, 2610 engagements
": BiotechTV is at the @sitcancer annual meeting this weekend. We are kicking things off by speaking with @MyOncology CEO of @MarengoTx and an expert in the field to get his take on key data and themes. $SMMT"
X Link 2025-11-07T19:55Z 9909 followers, 12.5K engagements
": Ipsen has done a string of deals over recent years including acquiring ImCheck last month. CEO David Loew says the company has billions in firepower to do more. Full video:"
X Link 2025-11-19T19:46Z 9909 followers, 1814 engagements
": Dropping by the @BeOneMedicines booth at ASH and visiting with @johnvoyler. Plus what does a CEO do at a conference like this"
X Link 2025-12-06T21:39Z 9911 followers, 2035 engagements
": @CullinanTx's CEO Nadim Ahmed highlights the company's FLT3xCD3 bispecific T-cell engager data at ASH in AML and MDS. $CGEM Full video:"
X Link 2025-12-08T19:55Z 9911 followers, 4763 engagements
": Checking in (quickly) with @TernsPharma CEO Amy Burroughs on the tern-701 data at ASH. $TERN"
X Link 2025-12-08T23:49Z 9911 followers, 17.6K engagements
": Corvus CEO Richard Miller believes that ITK inhibitors can have the same broad impact on T-cell diseases as BTK inhibitors have had on B-cell diseases - he would know. $CRVS Full video:"
X Link 2025-12-09T00:20Z 9910 followers, 9540 engagements
": BiotechTV attended the ribbon cutting ceremony of Legend Biotechs new R&D center in Philadelphia today which is in the new 2300 Market life sciences building that was built by our sponsor @bt_prop. We caught up with Legend CEO Ying Huang there"
X Link 2025-11-13T20:22Z 9911 followers, 1839 engagements
": @EpiBoneInc creates bones and cartilage grown from stem cells - Co-Founder and CEO @ninatandon describes the creative thinking she has used to accelerate its availability. Full video:"
X Link 2025-12-11T12:30Z 9910 followers, XXX engagements
": The leaders of London based @labgeni_us discuss a recent ESMO IO poster for their Nectin-4 x CD3 T-cell engager and a new expanded collaboration with Sanofi on antibody optimization. Full video:"
X Link 2025-12-11T17:06Z 9911 followers, XXX engagements